Z-160

N/A

Report date: 2022/11/25 17:57:40
NME

Base Information

Drug NameZ-160
Drug Alias NameZ-160NP-118809NMED-160MK-6721
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunit
Therapy Area/IndicationsRadiculopathyNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEpirus Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsRadiculopathyNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A